Journal Article Summary
The article investigates the effectiveness and safety of leukotriene receptor antagonists (LTRAs) for treating eczema, a common and chronic skin condition often linked to other allergic disorders like asthma. Eczema can significantly impact a person's quality of life, and while corticosteroids are a standard treatment, they can have undesirable side effects with long-term use. Given the limited options for managing eczema and the potential for LTRAs to reduce reliance on corticosteroids, understanding their role in eczema treatment is important for patients and healthcare providers.
The review included five studies with a total of 202 participants, all of whom had moderate-to-severe eczema. The studies primarily focused on the LTRA montelukast, administered at doses of 5 mg or 10 mg, and compared its effects to placebo or conventional treatments like topical corticosteroids. The findings indicated no significant improvement in eczema severity when comparing montelukast to placebo, and the evidence regarding its effectiveness was deemed low quality. While one study suggested a potential benefit of montelukast over conventional treatment, the overall results were inconclusive, and many outcomes, such as long-term control and quality of life, were not assessed.
Limitations of the review include the small number of studies and participants, as well as the focus solely on montelukast, which restricts the generalizability of the findings. Additionally, many important outcomes were not evaluated, leaving uncertainty about the long-term effectiveness and safety of LTRAs for eczema. Patients should consult with their healthcare professionals to discuss treatment options, especially if they are considering LTRAs, and to ensure they are using the most effective and safe therapies for managing eczema.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Ferguson Leila, Futamura Masaki, Vakirlis Efstratios, Kojima Reiji, Sasaki Hatoko, Roberts Amanda, Mori Rintaro. Leukotriene receptor antagonists for eczema. The Cochrane Database of Systematic Reviews 2018. DOI: 10.1002/14651858.CD011224.pub2. PMID: 30343498. PMCID: PMC6517006.
Featured Pill Pals Product
Montelukast 10 mg Tablets --- Generic For Singulair --- Camber
Montelukast 10 mg Tablets — Generic For Singulair — Camber is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
